申请人:Bayer Aktiengesellschaft
公开号:US05721238A1
公开(公告)日:1998-02-24
2,8-Disubstituted quinazolinones are prepared by first subjecting the quinazolinone basic skeleton to condensation by customary reactions and then introducing the desired substituents into the 8-position. The compounds are suitable as active compounds in medicaments, in particular for the treatment of inflammations, thromboembolic diseases and cardiovascular diseases.
首先,通过惯例反应将quinazolinone基本骨架进行缩合,然后在8位引入所需的取代基,制备2,8-二取代的quinazolinones。这些化合物适用于药物中的活性化合物,特别是用于治疗炎症、血栓栓塞性疾病和心血管疾病。